Clinical Trial: A Study to Assess the Potential CYP3A Induction Effect of Brensocatib on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07859007) titled 'A Study to Assess the Potential CYP3A Induction Effect of Brensocatib on the Pharmacokinetics (PK) of Midazolam in Healthy Participants' on Sept. 29.

Brief Summary: The primary objective of this study is to assess the effect of multiple doses of brensocatib on the single dose PK of oral midazolam when coadministered in healthy male and female participants.

Study Start Date: Oct. 29

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Brensocatib

Oral tablets

DRUG: Midazolam

Oral solution

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Insmed Incorporated

Disclaimer: Curated by HT Syndication....